A compound of the formula (I) or a pharmaceutically acceptable salt, enantiomer, racemate, diasteromers or mixtures thereof, or a solvate thereof, formulations and methods of use thereof, as opioid receptor antagonists are disclosed wherein the variables are as described herein.

 
Web www.patentalert.com

< Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors

> INHIBITORS OF MELANOCYTE TYROSINASE AS TOPICAL SKIN LIGHTENERS

~ 00494